Effectiveness of a Family Support Model for Prevention and Management of Overweight and Obesity in Children 6-12 Years
NCT ID: NCT07158944
Last Updated: 2025-09-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
126 participants
INTERVENTIONAL
2025-09-30
2028-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis is that combining the Healthy School Start and More and Less programs in a coherent model will increase the collaboration between regional and municipal stakeholders, ensure early identification of families in need, ultimately improving prevention and treatment of childhood overweight and obesity. The aim of this study is to evaluate the implementation of a coherent model of family support provided through school and primary health care.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Healthy School Start Plus Intervention Study
NCT03390725
Overweight and Obesity in Preschoolers
NCT03800823
Early Stockholm Obesity Prevention Program
NCT01198847
Group Sessions and Web-based Treatment Targeting Children With Obesity Age 5-12 Years and Their Families
NCT04013230
HRQoL in Overweight and Obese Children/Adolescents
NCT05424094
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Receives A Healthy School Start and the More and Less program
More and Less
Dose: 10 group sessions + 6 individual booster sessions Frequency: 10 weekly group sessions (10 weeks) 6 booster sessions every 6th week
Control
Receives A Healthy School Start and standard treatment for overweight or obesity
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
More and Less
Dose: 10 group sessions + 6 individual booster sessions Frequency: 10 weekly group sessions (10 weeks) 6 booster sessions every 6th week
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The child attends a school providing the Healthy School Start program.
* The child has been diagnosed with overweight (age standardized BMI of 25 or above) or obesity (age standardized BMI of 30 or above) by a health care personnel.
Exclusion Criteria
6 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Liselotte Schäfer Elinder
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Liselotte S Elinder, Professor
Role: PRINCIPAL_INVESTIGATOR
Karolinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Primary healthcare
Södertälje, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
Information about the Co-fam study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-02536
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
20230923
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
20250603
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2025-01385-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.